Invention Grant
- Patent Title: MAGL inhibitors
-
Application No.: US16739642Application Date: 2020-01-10
-
Publication No.: US11214557B2Publication Date: 2022-01-04
- Inventor: Cheryl A. Grice , Daniel J. Buzard , Michael B. Shaghafi
- Applicant: H. Lundbeck A/S
- Applicant Address: DK Valby
- Assignee: H. Lundbeck A/S
- Current Assignee: H. Lundbeck A/S
- Current Assignee Address: DK Valby
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C07D295/185
- IPC: C07D295/185 ; C07D305/08 ; C07D213/55 ; C07D241/12 ; C07D263/32 ; C07D305/06
Abstract:
Provided herein are piperazine carbamates and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of MAGL. Furthermore, the subject compounds and compositions are useful for the treatment of pain.
Public/Granted literature
- US20200148653A1 MAGL INHIBITORS Public/Granted day:2020-05-14
Information query
